Clovis Davis Pharmaceuticals & Diagnostics is a specialty pharmaceutical company dedicated to advancing patient care through innovative pharmaceuticals and companion diagnostics. Our focus on niche disease areas enables us to provide healthcare professionals with differentiated solutions that improve disease detection, treatment access and clinical outcomes.
Key Therapeutic Areas:
• Oncology
• Women’s Health
• Companion Diagnostics
• Test-and-Treat Programs
DxPG80.Lab Test & Oncology Program
DxPG80.Lab Test
The DxPG80.Lab Test is an advanced blood-based biomarker designed to assist in the screening and monitoring of multiple cancer types. By enabling earlier identification of patients at risk, DxPG80 supports clinicians in making informed treatment decisions.
Integrated Test-and-Treat Strategy
Clovis Davis Pharmaceuticals & Diagnostics combines DxPG80 screening capabilities with an extensive oncology portfolio, creating a comprehensive pathway from diagnosis to treatment. This integrated approach supports earlier intervention, improved disease management and enhanced patient care.
Oncology Portfolio Structure
Cytotoxic Chemotherapy
Carboplatin
Cisplatin
Docetaxel
Paclitaxel
AB-Pacli
Gemcitabine
Doxorubicin
Epirubicin
Etoposide
Irinotecan
Vinorelbine
Fludarabine
Methotrexate
Peg L Asparaginase
Targeted Therapies
Gefitinib
Lenvatinib
Sunitinib
Sorafenib
Erlotinib
Lapatinib
Imatinib
Dasatinib
Bortezomib
Hormonal Oncology
Abiraterone
Bicalutamide
Anastrozole
Letrozole
Specialized Oncology
Temozolomide
Capecitabine
Thalidomide
Supportive Care
Pegfilgrastim
Zoledronic Acid
Fosaprepitant
Women’s Health
SOLOSEC® (secnidazole) 2g oral granules is a prescription medication indicated for the treatment of bacterial vaginosis in females aged 12 years and older. It is also approved for the treatment of Trichomoniasis, a common sexually transmitted infection (STI), in individuals 12 years of age and older.
Patients using SOLOSEC for Trichomoniasis should refrain from sexual activity until both they and their sexual partners have received the same dose at the same time. This helps reduce the risk of becoming infected again.
The safety and effectiveness of SOLOSEC in children younger than 12 years of age have not been established.
DailyMed Reference:
DailyMed – SOLOSEC- secnidazole granule
BV-Blue Diagnostic Test Kit & Solosec®
Clovis Davis Pharmaceuticals & Diagnostics offers an integrated Women’s Health Test-and-Treat Program combining the BV-Blue Diagnostic Test Kit with Solosec® (Secnidazole), an FDA-approved treatment exclusively secured through Evofem.
The program is designed to support rapid diagnosis and management of Bacterial Vaginosis (BV)
This integrated model provides healthcare professionals with a streamlined pathway from screening to treatment.